A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis

Stopped early · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Nonalcoholic Steatohepatitis (NASH), Overweight or Obesity

In brief

This Phase 1/2 study will evaluate safety, efficacy, PK, and PD of FT-4101 as a single agent in overweight/obese subjects with NASH. The study may be conducted in up to 2 dosing cohorts.

Key facts

Study ID
NCT04004325
Run by
Forma Therapeutics, Inc.
People needed
14
Starts
2019-05-17
Expected to finish
2020-01-20
Last updated by the study team
2025-10-20

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.